Nuvation Bio director granted 123,397 stock options

Nuvation Bio Inc. director Vernon W. Anthony received a grant of stock options covering 123,397 shares of Class A common stock.

Rhea-AI Filing Summary

Nuvation Bio Inc. director Vernon W. Anthony received a grant of stock options covering 123,397 shares of Class A common stock. The options have an exercise price of $4.79 per share and expire on May 20, 2036. All 123,397 shares subject to the option will vest on the earlier of May 21, 2026 or the next shareholder annual meeting, provided he remains in continuous service through that date. Following this compensation-related award, he holds 123,397 options directly, and the filing does not report any open-market buying or selling.

Insider Trade Summary

Grant/Award: 123,397 shares

Grant/Award 1 txn

Insider VERNON W ANTHONY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	123,397	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 123,397 contracts (Direct)

Footnotes (1)

1. F1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

Key Figures

Option grant size: 123,397 options Exercise price: $4.79 per share Expiration date: May 20, 2036 +2 more

5 metrics

Option grant size 123,397 options Stock Option (Right to Buy) granted to director on May 21, 2026

Exercise price $4.79 per share Conversion or exercise price of stock options

Expiration date May 20, 2036 Option expiration for granted stock options

Post-transaction options held 123,397 options Total derivative securities following the grant

Vesting reference date May 21, 2026 100% vesting on earlier of this date or next annual meeting

Key Terms

Stock Option (Right to Buy), Class A Common Stock, exercise price, vesting date, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Class A Common Stock financial

"underlying_security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

exercise price financial

"conversion_or_exercise_price: "4.7900" per share as exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting date financial

"vest on the earlier of the one-year anniversary or the next shareholder annual meeting vesting date"

expiration date financial

"expiration_date: "2036-05-20" listed as option expiration date"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nuvation Bio (NUVB) report for Vernon W. Anthony?

Nuvation Bio reported that director Vernon W. Anthony received a stock option grant for 123,397 shares. This is a compensation-related award, not an open-market trade, and gives him the right to buy Class A common stock at a fixed exercise price.

How many Nuvation Bio (NUVB) shares are covered by Vernon W. Anthony’s new stock options?

The new stock option grant covers 123,397 shares of Nuvation Bio Class A common stock. These options represent his entire reported derivative position in this filing, with 123,397 options shown as held directly following the award.

What is the exercise price and expiration date of Vernon W. Anthony’s NUVB options?

The granted stock options have an exercise price of $4.79 per share and expire on May 20, 2036. This means he can choose to buy Nuvation Bio Class A shares at $4.79 any time before the expiration date once the options are vested.

What is the vesting schedule for Vernon W. Anthony’s Nuvation Bio stock options?

All 123,397 option shares vest 100% on the earlier of May 21, 2026 or the next shareholder annual meeting. Vesting is subject to his continuous service with Nuvation Bio through the applicable vesting date, according to the filing’s footnote.

Did Vernon W. Anthony buy or sell Nuvation Bio (NUVB) shares in the market?

The filing shows a grant of stock options as compensation, not a market purchase or sale of shares. The transaction code is "A" for a grant or award acquisition, and no open-market buying or selling transactions are reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 08:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VERNON W ANTHONY

(Last) (First) (Middle)

C/O NUVATION BIO INC.

1500 BROADWAY, SUITE 1401

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvation Bio Inc. [ NUVB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.79	05/21/2026		A		123,397		(1)	05/20/2036	Class A Common Stock	123,397	$0	123,397	D

Explanation of Responses:

1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

	/s/ Stephen Dang, Attorney-in-Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)